Medical Illustration: Targeting HER2 in Gastric Cancer

April 15, 2016
Erin Moore

CURE, Gastrointestinal Special Issue, Volume 1, Issue 1

For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.

ILLUSTRATION BY ERIN MOORE

ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009

*HER2 is also associated with breast cancer.

For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.

Related Content:

PublicationsGastrointestinal CancersGastrointestinal Special Issue
GERD Might Cause Colonoscopy Avoidance. But Don’t Let It
Oncology Drugs Approved by the FDA in October 2024
Early Data Demonstrate Ablation May Alleviate Pain From Pancreatic Cancer